Pricing Log in Create free account

Kodiak Sciences Inc. (KOD) vs Mirum Pharmaceuticals, Inc. (MIRM)

Kodiak Sciences Inc. and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. Kodiak Sciences Inc. and Mirum Pharmaceuticals, Inc. are of similar size ($5.5B and $5.4B). Kodiak Sciences Inc. has the higher net margin (0.00% vs −139.2%) and the higher return on invested capital (0.00% vs −173.0%). Across the 13 metrics below, Kodiak Sciences Inc. leads on 8 and Mirum Pharmaceuticals, Inc. on 5.

Valuation

Metric KOD MIRM Biotechnology median
P/E n/m n/m 8.50
P/S n/m 8.22 9.71
P/B 87.90 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 8.73 9.21
Earnings yield (4.89%) (18.13%) (33.15%)
Free cash flow yield (2.98%) (5.39%) (25.50%)

Profitability

Metric KOD MIRM Biotechnology median
Gross margin 0.00% 81.72% 65.16%
Operating margin 0.00% (134.93%) 0.00%
Net margin 0.00% (139.18%) 0.00%
Free cash flow margin 0.00% (44.29%) 0.00%
Return on equity (368.37%) (702.97%) (56.36%)
Return on assets (94.25%) (97.15%) (48.04%)
Return on invested capital 0.00% (172.96%) 0.00%

Growth

Metric KOD MIRM Biotechnology median
Revenue growth (TTM) — 44.02% 6.02%
EPS growth (last fiscal year) (28.96%) 74.59% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KOD MIRM Biotechnology median
Debt to equity 0.00 (71.97) 0.00
Current ratio 2.49 2.86 4.72
Net debt to EBITDA 1.01 (19.11) 0.96

Dividend

Metric KOD MIRM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KOD MIRM Biotechnology median
Market cap 5.54b 5.35b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack